|
Welcome to the TDN Op Ed page, where a selected stable of writers will, from time to time, offer their opinion and perspective on matters concerning the racing industry. The viewpoints expressed herein are not necessarily those of the management, but promise to represent what we consider to be responsible comment.
Comments? Please respond to TDN management at suefinley@thoroughbreddailynews.com.
|
Matt F. Iuliano became the executive vice president and executive director of The Jockey Club, the breed registry for all Thoroughbred horses in North America, on January 1, 2010, after more than eight years as the organization's vice president of registration services. He oversees all matters concerning The American Stud Book and represents The Jockey Club as it interacts with industry committees and organizations, including the Thoroughbred Safety Committee and the Racing Medication & Testing Consortium. Iuliano joined The Jockey Club staff in June 2001. Prior to that, he served in several executive capacities at Churchill Downs Incorporated over the course of a 12-year stint. He received a bachelor's degree in agriculture and a master's degree in physiology and biophysics from Colorado State University before earning an MBA and a law degree from the University of Louisville. |
- 11/5/2010 - THE MCKINSEY REPORT: A RETROSPECTIVE
If there is a document or report in the Thoroughbred industry that is cited or mentioned more often than the "McKinsey Report," I am not aware of it. Almost any discussion of drugs and medication in our sport eventually leads back to a mention of that seminal report of 1991. — (click here to read the entire article)
Click here to go back to the op/ed section.
|
![Click here to download Today's Edition [3.94Mb - PDF]](/graphics/member_menu_todaysedition3.gif)
![Click HERE to view today's edition in your browser [3.94Mb - PDF]](/graphics/member_menu_today_view2.gif){kind=small}
![Click HERE to save today's edition to your computer [3.94Mb - PDF]](/graphics/member_menu_today_save2.gif){kind=small}
For the best site experience, the latest version of Adobe Acrobat Reader is suggested. Click here to get it free.
